Ureteropelvic Junction Obstruction in Early Childhood: Comparison of Surgical Therapy and Surveillance. A Prospective, Randomized, Controlled Multi-Center Study
NCT ID: NCT00444431
Last Updated: 2007-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robot-Assisted Pyeloplasty in Young Children
NCT06734455
Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
NCT02419339
Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children
NCT04384939
Ultrasonographic Versus Renographic Parameters in Prediction of Early Success After Pyeloplasty in Children
NCT03939091
Cost-Effectiveness and Clinical Outcomes of Double J Stent Versus Percutaneous Feeding Tube Placement Following Open Pyeloplasty in Pediatric Patients: A Prospective Randomized Single-center Study
NCT06847841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pyeloplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diameter of renal pelvis greater 12 mm
* partial renal function of 35%-55% proofed by scintigraphy
* urodynamically relevant decrease in renal drainage proofed by diuresis scintigraphy at the age of 4 weeks up to 6 months
* Abscence of clinical symptoms
* Healthy contralateral kidney
Exclusion Criteria
* renal dystopia
* megaureter
* vesico-ureteral reflux
* progressive hydronephrosis
* oligohydrammnion
* voiding dysfunction
* bilateral hydronephrosis
* severe chronical illness
* decrease of partial renal function of more then 5% during allocation
4 Months
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Essen
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Herbert Rübben, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Essen
Peter Hoyer, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Essen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Essen, Department of Pediatric Nephrology
Essen, North Rhine-Westphalia, Germany
University Hospital of Essen, Department of Urology
Essen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005-004090-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.